|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2005-11-7
|
|
pubmed:abstractText |
The objective of this study was to identify prognostic factors for predicting survival in patients with advanced renal cell carcinoma (RCC) who had undergone an allogeneic stem cell transplantation after failure on immunotherapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
pubmed-author:BarkholtLisbethL,
pubmed-author:BregniMarcoM,
pubmed-author:BruzziPaoloP,
pubmed-author:CiceriFabioF,
pubmed-author:CorradiniPaoloP,
pubmed-author:Da PradaGian AntonioGA,
pubmed-author:DemirerTannerT,
pubmed-author:European Bone Marrow Transplantation Solid Tumor Working Party,
pubmed-author:LenhoffStigS,
pubmed-author:MartinoRodrigoR,
pubmed-author:MassenkeilGeroG,
pubmed-author:NiederwieserDietgerD,
pubmed-author:PeccatoriJacopoJ,
pubmed-author:PedrazzoliPaoloP,
pubmed-author:RingdenOlleO,
pubmed-author:RostiGiovanniG,
pubmed-author:SienaSalvatoreS,
pubmed-author:SormaniMaria PiaMP,
pubmed-author:ZambelliAlbertoA
|
|
pubmed:copyrightInfo |
Copyright 2005 American Cancer Society
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
104
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2099-103
|
|
pubmed:dateRevised |
2009-6-26
|
|
pubmed:meshHeading |
pubmed-meshheading:16220555-C-Reactive Protein,
pubmed-meshheading:16220555-Carcinoma, Renal Cell,
pubmed-meshheading:16220555-Humans,
pubmed-meshheading:16220555-Karnofsky Performance Status,
pubmed-meshheading:16220555-Kidney Neoplasms,
pubmed-meshheading:16220555-L-Lactate Dehydrogenase,
pubmed-meshheading:16220555-Prognosis,
pubmed-meshheading:16220555-Stem Cell Transplantation,
pubmed-meshheading:16220555-Survival Analysis,
pubmed-meshheading:16220555-Transplantation, Homologous
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Prognostic factors for survival in patients with advanced renal cell carcinoma undergoing nonmyeloablative allogeneic stem cell transplantation.
|
|
pubmed:affiliation |
Hematology-Bone Marrow Transplant Unit, Istituto Scientifico H. San Raffaele, Milano, Italy.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
